Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits

K. Sas, K. Csete, Z. Vezekényi, L. Sztriha, L. Vécsei, J. Papp

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Depression, which is associated with an increased incidence of vascular events, frequently occurs following stroke. Selective serotonin reuptake inhibitory drugs (SSRIs) as antidepressants, are well tolerated, and also seem to be effective in post-stroke depression. The aim of this study was to investigate the effects of the SSRIs citalopram and fluoxetine, on the corticocerebral blood flow (cCBF) in rabbits with unilateral carotid occlusion induced cerebral ischemia. The cCBF was measured by the hydrogen clearance technique. After determination of the mean baseline cCBF, the effects of individual doses (0.1, 0.3 and 1 mg/ kg) of citalopram or fluoxetine on the cCBF were investigated. Following the induction of an impaired cCBF, the changes in cCBF after drug treatments in this condition were likewise measured. The mean arterial blood pressure (MABP) and the heart rate (HR) from the electrocardiogram (ECG) were also determined. Neither citalopram nor fluoxetine influenced the cCBF in the control group. Fluoxetine improved the cCBF only very slightly in the ischemic animals. In contrast, all the doses of citalopram exerted pronounced and dose-dependent cCBF-increasing effects in the animals with unilateral carotid occlusion (maximal mean ΔCBF: 10, 16 and 27 ml/min/100 g tissue). The HR was decreased in both groups. Only citalopram treatment led to a slight MABP-decreasing effect. Besides enhancement of the serotonergic transmission in the brain, the cCBF-increasing effect of citalopram under ischemic conditions may be of benefit in post-stroke and vascular depression.

Original languageEnglish
Pages (from-to)167-177
Number of pages11
JournalActa Physiologica Hungarica
Volume94
Issue number3
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Citalopram
Fluoxetine
Cerebral Cortex
Rabbits
Arterial Pressure
Stroke
Blood Vessels
Serotonin
Heart Rate
Brain Ischemia
Pharmaceutical Preparations
Antidepressive Agents
Hydrogen
Electrocardiography

Keywords

  • Citalopram
  • Conscious
  • Corticocerebral blood flow
  • Fluoxetine
  • Hydrogen polarography
  • Rabbits

ASJC Scopus subject areas

  • Physiology

Cite this

Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits. / Sas, K.; Csete, K.; Vezekényi, Z.; Sztriha, L.; Vécsei, L.; Papp, J.

In: Acta Physiologica Hungarica, Vol. 94, No. 3, 09.2007, p. 167-177.

Research output: Contribution to journalArticle

@article{3abb0a93bd064270bfad176929af8999,
title = "Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits",
abstract = "Depression, which is associated with an increased incidence of vascular events, frequently occurs following stroke. Selective serotonin reuptake inhibitory drugs (SSRIs) as antidepressants, are well tolerated, and also seem to be effective in post-stroke depression. The aim of this study was to investigate the effects of the SSRIs citalopram and fluoxetine, on the corticocerebral blood flow (cCBF) in rabbits with unilateral carotid occlusion induced cerebral ischemia. The cCBF was measured by the hydrogen clearance technique. After determination of the mean baseline cCBF, the effects of individual doses (0.1, 0.3 and 1 mg/ kg) of citalopram or fluoxetine on the cCBF were investigated. Following the induction of an impaired cCBF, the changes in cCBF after drug treatments in this condition were likewise measured. The mean arterial blood pressure (MABP) and the heart rate (HR) from the electrocardiogram (ECG) were also determined. Neither citalopram nor fluoxetine influenced the cCBF in the control group. Fluoxetine improved the cCBF only very slightly in the ischemic animals. In contrast, all the doses of citalopram exerted pronounced and dose-dependent cCBF-increasing effects in the animals with unilateral carotid occlusion (maximal mean ΔCBF: 10, 16 and 27 ml/min/100 g tissue). The HR was decreased in both groups. Only citalopram treatment led to a slight MABP-decreasing effect. Besides enhancement of the serotonergic transmission in the brain, the cCBF-increasing effect of citalopram under ischemic conditions may be of benefit in post-stroke and vascular depression.",
keywords = "Citalopram, Conscious, Corticocerebral blood flow, Fluoxetine, Hydrogen polarography, Rabbits",
author = "K. Sas and K. Csete and Z. Vezek{\'e}nyi and L. Sztriha and L. V{\'e}csei and J. Papp",
year = "2007",
month = "9",
doi = "10.1556/APhysiol.94.2007.3.1",
language = "English",
volume = "94",
pages = "167--177",
journal = "Physiology International",
issn = "2498-602X",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits

AU - Sas, K.

AU - Csete, K.

AU - Vezekényi, Z.

AU - Sztriha, L.

AU - Vécsei, L.

AU - Papp, J.

PY - 2007/9

Y1 - 2007/9

N2 - Depression, which is associated with an increased incidence of vascular events, frequently occurs following stroke. Selective serotonin reuptake inhibitory drugs (SSRIs) as antidepressants, are well tolerated, and also seem to be effective in post-stroke depression. The aim of this study was to investigate the effects of the SSRIs citalopram and fluoxetine, on the corticocerebral blood flow (cCBF) in rabbits with unilateral carotid occlusion induced cerebral ischemia. The cCBF was measured by the hydrogen clearance technique. After determination of the mean baseline cCBF, the effects of individual doses (0.1, 0.3 and 1 mg/ kg) of citalopram or fluoxetine on the cCBF were investigated. Following the induction of an impaired cCBF, the changes in cCBF after drug treatments in this condition were likewise measured. The mean arterial blood pressure (MABP) and the heart rate (HR) from the electrocardiogram (ECG) were also determined. Neither citalopram nor fluoxetine influenced the cCBF in the control group. Fluoxetine improved the cCBF only very slightly in the ischemic animals. In contrast, all the doses of citalopram exerted pronounced and dose-dependent cCBF-increasing effects in the animals with unilateral carotid occlusion (maximal mean ΔCBF: 10, 16 and 27 ml/min/100 g tissue). The HR was decreased in both groups. Only citalopram treatment led to a slight MABP-decreasing effect. Besides enhancement of the serotonergic transmission in the brain, the cCBF-increasing effect of citalopram under ischemic conditions may be of benefit in post-stroke and vascular depression.

AB - Depression, which is associated with an increased incidence of vascular events, frequently occurs following stroke. Selective serotonin reuptake inhibitory drugs (SSRIs) as antidepressants, are well tolerated, and also seem to be effective in post-stroke depression. The aim of this study was to investigate the effects of the SSRIs citalopram and fluoxetine, on the corticocerebral blood flow (cCBF) in rabbits with unilateral carotid occlusion induced cerebral ischemia. The cCBF was measured by the hydrogen clearance technique. After determination of the mean baseline cCBF, the effects of individual doses (0.1, 0.3 and 1 mg/ kg) of citalopram or fluoxetine on the cCBF were investigated. Following the induction of an impaired cCBF, the changes in cCBF after drug treatments in this condition were likewise measured. The mean arterial blood pressure (MABP) and the heart rate (HR) from the electrocardiogram (ECG) were also determined. Neither citalopram nor fluoxetine influenced the cCBF in the control group. Fluoxetine improved the cCBF only very slightly in the ischemic animals. In contrast, all the doses of citalopram exerted pronounced and dose-dependent cCBF-increasing effects in the animals with unilateral carotid occlusion (maximal mean ΔCBF: 10, 16 and 27 ml/min/100 g tissue). The HR was decreased in both groups. Only citalopram treatment led to a slight MABP-decreasing effect. Besides enhancement of the serotonergic transmission in the brain, the cCBF-increasing effect of citalopram under ischemic conditions may be of benefit in post-stroke and vascular depression.

KW - Citalopram

KW - Conscious

KW - Corticocerebral blood flow

KW - Fluoxetine

KW - Hydrogen polarography

KW - Rabbits

UR - http://www.scopus.com/inward/record.url?scp=34848916035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848916035&partnerID=8YFLogxK

U2 - 10.1556/APhysiol.94.2007.3.1

DO - 10.1556/APhysiol.94.2007.3.1

M3 - Article

C2 - 17853768

AN - SCOPUS:34848916035

VL - 94

SP - 167

EP - 177

JO - Physiology International

JF - Physiology International

SN - 2498-602X

IS - 3

ER -